Ontology highlight
ABSTRACT:
SUBMITTER: Fischer K
PROVIDER: S-EPMC7727567 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
Hematology. American Society of Hematology. Education Program 20201201 1
Recent developments in the management of chronic lymphocytic leukemia (CLL) have moved the standard of care away from chemoimmunotherapy to targeted agents such as oral kinase inhibitors or BCL-2 antagonists, alone or in combination with anti-CD20 antibodies. Two different treatment approaches have evolved: continuous, indefinite treatment and, more recently, fixed-duration combination treatment. With venetoclax-based treatment, there is a requirement to follow the established guidelines for clo ...[more]